William Byne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William Byne has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
A. Evan Eyler
Departments of Psychiatry and Family Medicine, University of Vermont College of Medicine, Burlington, Vermont
2 shared publicationsAlex Tatusov
A Division of Basic and Laboratory Research, Bronx Veterans Affairs Medical Center, Bronx, NY 10467
2 shared publicationsEli Coleman
Program in Human Sexuality, Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota
2 shared publicationsGeorgia Yiannoulos
A Division of Basic and Laboratory Research, Bronx Veterans Affairs Medical Center, Bronx, NY 10467
2 shared publicationsRichard R. Pleak
Department of Psychiatry, Division of Child and Adolescent Psychiatry, Hofstra North Shore-LIJ School of Medicine, Albert Einstein College of Medicine, Zucker Hillside Hospital, Ambulatory Care Pavilion, Glen Oaks, New York
2 shared publicationsA Tatusov
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, United States
1 shared publication
Latest Publications
- Open Access
- 1 December 2018
- Published by SAGE Publications in Transgender Health
- Vol. 3 (1) , 57-A3
Gender Dysphoria in Adults: An Overview and Primer for Psychiatrists
Regardless of their area of specialization, adult psychiatrists are likely to encounter gender-variant patients; however, medical school curricula and psychiatric residency training programs devote little attention to their care. This article aims to assist adult psychiatrists who are not gender specialists in the delivery of respectful, clinically competent, and culturally attuned care to gender-variant patients, including those who identify as transgender or transsexual or meet criteria for the diagnosis of Gender Dysphoria (GD) as defined by The Diagnostic and Statistical Manual of Mental Disorders (5th edition). The article will also be helpful for other mental health professionals. The following areas are addressed: evolution of diagnostic nosology, epidemiology, gender development, and mental health assessment, differential diagnosis, treatment, and referral for gender-affirming somatic treatments of adults with GD.
- 1 December 2018
- Published by SAGE Publications in Transgender Health
- Vol. 3 (1) , 57-A3
Open AccessGender Dysphoria in Adults: An Overview and Primer for Psychiatrists
Regardless of their area of specialization, adult psychiatrists are likely to encounter gender-variant patients; however, medical school curricula and psychiatric residency training programs devote little attention to their care. This article aims to assist adult psychiatrists who are not gender specialists in the delivery of respectful, clinically competent, and culturally attuned care to gender-variant patients, including those who identify as transgender or transsexual or meet criteria for the diagnosis of Gender Dysphoria (GD) as defined by The Diagnostic and Statistical Manual of Mental Disorders (5th edition). The article will also be helpful for other mental health professionals. The following areas are addressed: evolution of diagnostic nosology, epidemiology, gender development, and mental health assessment, differential diagnosis, treatment, and referral for gender-affirming somatic treatments of adults with GD.
- 1 January 2018
- Published by SAGE Publications in LGBT Health
- Vol. 5 (1) , 1-5
Resilience and Action in a Challenging Time for LGBT Rights
- 1 January 2018
- Published by SAGE Publications in LGBT Health
- Vol. 5 (1) , 1-5
Resilience and Action in a Challenging Time for LGBT Rights
- Open Access
DNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age
We employed Illumina 450 K Infinium microarrays to profile DNA methylation (DNAm) in neuronal nuclei separated by fluorescence-activated sorting from the postmortem orbitofrontal cortex (OFC) of heroin users who died from heroin overdose (N = 37), suicide completers (N = 22) with no evidence of heroin use and from control subjects who did not abuse illicit drugs and died of non-suicide causes (N = 28). We identified 1298 differentially methylated CpG sites (DMSs) between heroin users and controls, and 454 DMSs between suicide completers and controls (p < 0.001). DMSs and corresponding genes (DMGs) in heroin users showed significant differences in the preferential context of hyper and hypo DM. HyperDMSs were enriched in gene bodies and exons but depleted in promoters, whereas hypoDMSs were enriched in promoters and enhancers. In addition, hyperDMGs showed preference for genes expressed specifically by glutamatergic as opposed to GABAergic neurons and enrichment for axonogenesis- and synaptic-related gene ontology categories, whereas hypoDMGs were enriched for transcription factor activity- and gene expression regulation-related terms. Finally, we found that the DNAm-based “epigenetic age” of neurons from heroin users was younger than that in controls. Suicide-related results were more difficult to interpret. Collectively, these findings suggest that the observed DNAm differences could represent functionally significant marks of heroin-associated plasticity in the OFC.
Open AccessDNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age
We employed Illumina 450 K Infinium microarrays to profile DNA methylation (DNAm) in neuronal nuclei separated by fluorescence-activated sorting from the postmortem orbitofrontal cortex (OFC) of heroin users who died from heroin overdose (N = 37), suicide completers (N = 22) with no evidence of heroin use and from control subjects who did not abuse illicit drugs and died of non-suicide causes (N = 28). We identified 1298 differentially methylated CpG sites (DMSs) between heroin users and controls, and 454 DMSs between suicide completers and controls (p < 0.001). DMSs and corresponding genes (DMGs) in heroin users showed significant differences in the preferential context of hyper and hypo DM. HyperDMSs were enriched in gene bodies and exons but depleted in promoters, whereas hypoDMSs were enriched in promoters and enhancers. In addition, hyperDMGs showed preference for genes expressed specifically by glutamatergic as opposed to GABAergic neurons and enrichment for axonogenesis- and synaptic-related gene ontology categories, whereas hypoDMGs were enriched for transcription factor activity- and gene expression regulation-related terms. Finally, we found that the DNAm-based “epigenetic age” of neurons from heroin users was younger than that in controls. Suicide-related results were more difficult to interpret. Collectively, these findings suggest that the observed DNAm differences could represent functionally significant marks of heroin-associated plasticity in the OFC.
- 1 February 2017
- Published by SAGE Publications in LGBT Health
- Vol. 4 (1) , 1-3
Sustaining Progress Toward LGBT Health Equity: A Time for Vigilance, Advocacy, and Scientific Inquiry
- 1 February 2017
- Published by SAGE Publications in LGBT Health
- Vol. 4 (1) , 1-3
Sustaining Progress Toward LGBT Health Equity: A Time for Vigilance, Advocacy, and Scientific Inquiry
- 1 June 2016
- Published by SAGE Publications in LGBT Health
- Vol. 3 (3) , 180
Leaders in LGBT Health
- 1 April 2016
- Published by SAGE Publications in LGBT Health
- Vol. 3 (2) , 97-99
Regulations Restrict Practice of Conversion Therapy
- 1 April 2016
- Published by SAGE Publications in LGBT Health
- Vol. 3 (2) , 97-99
Regulations Restrict Practice of Conversion Therapy
- 1 December 2015
- Published by SAGE Publications in LGBT Health
- Vol. 2 (4) , 285-286
Priorities to Address Gaps in LGBT Health Research
- 1 December 2015
- Published by SAGE Publications in LGBT Health
- Vol. 2 (4) , 285-286
Priorities to Address Gaps in LGBT Health Research
- 1 September 2015
- Published by SAGE Publications in LGBT Health
- Vol. 2 (3) , 193-195
LGBT Health Equity: Steps Toward Progress and Challenges Ahead
- 1 September 2015
- Published by SAGE Publications in LGBT Health
- Vol. 2 (3) , 193-195
LGBT Health Equity: Steps Toward Progress and Challenges Ahead
- 1 March 2015
- Published by SAGE Publications in LGBT Health
- Vol. 2 (1) , 1-2
LGBT Health: Going Strong as We Begin Our Second Year
- 1 March 2015
- Published by SAGE Publications in LGBT Health
- Vol. 2 (1) , 1-2
LGBT Health: Going Strong as We Begin Our Second Year